These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 25251588
1. Inflammatory and bone turnover markers in a cross-sectional and prospective study of acute Charcot osteoarthropathy. Petrova NL, Dew TK, Musto RL, Sherwood RA, Bates M, Moniz CF, Edmonds ME. Diabet Med; 2015 Feb; 32(2):267-73. PubMed ID: 25251588 [Abstract] [Full Text] [Related]
3. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Petrova NL, Foster AV, Edmonds ME. Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628 [Abstract] [Full Text] [Related]
7. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, Donohoe M, Foster AV, Edmonds ME, Boulton AJ. Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835 [Abstract] [Full Text] [Related]
8. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K. J Clin Endocrinol Metab; 1996 Oct; 81(10):3450-4. PubMed ID: 8855783 [Abstract] [Full Text] [Related]
10. Bone turnover in prolonged critical illness: effect of vitamin D. Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. J Clin Endocrinol Metab; 2003 Oct; 88(10):4623-32. PubMed ID: 14557432 [Abstract] [Full Text] [Related]
14. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women. Kaji T, Yasui T, Suto M, Mitani R, Morine M, Uemura H, Maeda K, Irahara M. Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597 [Abstract] [Full Text] [Related]
15. Effects of a 4-month recruit training program on markers of bone metabolism. Evans RK, Antczak AJ, Lester M, Yanovich R, Israeli E, Moran DS. Med Sci Sports Exerc; 2008 Nov; 40(11 Suppl):S660-70. PubMed ID: 18849868 [Abstract] [Full Text] [Related]
16. Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. Anastasilakis AD, Polyzos SA, Gkiomisi A, Bisbinas I, Gerou S, Makras P. J Clin Endocrinol Metab; 2013 Aug; 98(8):3206-12. PubMed ID: 23788684 [Abstract] [Full Text] [Related]
17. Response of Bone Turnover Markers and Cytokines to High-Intensity Low-Impact Exercise. Mezil YA, Allison D, Kish K, Ditor D, Ward WE, Tsiani E, Klentrou P. Med Sci Sports Exerc; 2015 Jul; 47(7):1495-502. PubMed ID: 25373482 [Abstract] [Full Text] [Related]
18. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Woo JH, Lee HJ, Sung IH, Kim TH. J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317 [Abstract] [Full Text] [Related]